Tatva Chintan Pharma Chem consolidated net profit declines 17.09% in the March 2022 quarter

25 Apr 2022 , 04:43 PM

Net profit of Tatva Chintan Pharma Chem declined 17.09% to Rs 17.51 crore in the quarter ended March 2022 as against Rs 21.12 crore during the previous quarter ended March 2021. Sales declined 9.33% to Rs 98.53 crore in the quarter ended March 2022 as against Rs 108.67 crore during the previous quarter ended March 2021.

For the full year,net profit rose 83.45% to Rs 95.87 crore in the year ended March 2022 as against Rs 52.26 crore during the previous year ended March 2021. Sales rose 44.38% to Rs 433.65 crore in the year ended March 2022 as against Rs 300.36 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	98.53	108.67	-9	433.65	300.36	44
OPM %	22.29	22.52	–	24.96	22.12	–
PBDT	21.12	26.01	-19	112.30	67.43	67
PBT	18.98	24.24	-22	104.12	60.70	72
NP	17.51	21.12	-17	95.87	52.26	83

Powered by Capital Market – Live News